Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05597306 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia, in Relapse

Interventions

DRUG: Bomedemstat
DRUG: Venetoclax

Sponsor

Terrence J Bradley, MD

Collaborators

[object Object]